Treatment with pegylated interferon ( peg-IFN ) alfa-@a ( @KD ) results in hepatitis B `` e '' antigen ( HBeAg ) seroconversion @ months after treatment in up to @ % of HBeAg-positive chronic hepatitis B patients .